Regulatory News
Friday, January 27, 2017
BRIEF-Aurinia selects Worldwide Clinical Trials as its CRO for Phase 3 lupus nephritis trial
* Aurinia selects Worldwide Clinical Trials as its CRO for
Phase 3 lupus nephritis trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment